• Latest Posts

CDF15 cytokine a promising therapeutic target against type 2 diabetes

Needle-free diabetes care: 7 devices that painlessly monitor blood sugar

Beyond Biotech podcast 16: Adocia, Omnio, Phenomix Sciences, Tridek-One

Ilya Pharma enrols first patient in diabetic foot ulcer study

New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug

Positive results from Arecor Therapeutics’ clinical trial of rapid, concentrated insulin


CellResearch Corporation announces positive results of phase I diabetic foot ulcer study

More News! 16 Sep 2022

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

Adocia takes steps with implants for treatment of type 1 diabetes

Provention Bio looks to advance diabetes drug through $125M loan

Enrollment completed for trial looking at treatment of diabetic kidney disease